What is Atlantic Dermatologic Associates?
Atlantic Dermatologic Associates operates as a comprehensive clinical practice specializing in advanced dermatological care. The firm provides a robust suite of services ranging from essential medical dermatology and complex Mohs surgery to high-margin cosmetic therapies such as laser skin resurfacing, Botox, and platelet-rich plasma treatments. With a strategic presence spanning from Brooklyn to Bellmore, the practice distinguishes itself through a patient-centric approach that integrates innovative clinical techniques with personalized care protocols. By maintaining a diverse service portfolio, the company effectively captures both the medical necessity market and the growing demand for aesthetic enhancements, establishing itself as a key player in the regional healthcare sector.
How much funding has Atlantic Dermatologic Associates raised?
Atlantic Dermatologic Associates has raised a total of $867K across 2 funding rounds:
Debt
$350K
Debt
$517K
Debt (2020): $350K with participation from PPP
Debt (2021): $517K led by PPP
Key Investors in Atlantic Dermatologic Associates
PPP
Public-Private Partnership
What's next for Atlantic Dermatologic Associates?
With the recent capital injection, Atlantic Dermatologic Associates is expected to prioritize the expansion of its clinical infrastructure and the adoption of next-generation dermatological technologies. The strategic focus will likely shift toward optimizing operational efficiencies across its existing locations while exploring potential geographic growth opportunities within the New York market. As the practice scales, the integration of advanced diagnostic tools and the expansion of its cosmetic service line will be critical in maintaining its competitive edge. The firm's ability to manage its debt-to-equity profile while scaling its service volume will be a key indicator of its long-term sustainability and potential for further institutional backing.
See full Atlantic Dermatologic Associates company page
